Tag: Biotech

Biotech player turned Ottawa Senators owner Eugene Melnyk faces off against COVID-19



Eugene Melnyk looking at the camera: Of all people, Eugene Melnyk knows how difficult it can be to make a buck off hockey, even in Canada, even pre-COVID.


© Provided by Financial Post
Of all people, Eugene Melnyk knows how difficult it can be to make a buck off hockey, even in Canada, even pre-COVID.

Eugene Melnyk is leafing through a 112-page document at his home in Barbados, sipping on a caffeine-free, citrus-flavoured drink. The document, he said, was a plan, the master plan detailing how, position by position and player by player, the Ottawa Senators, of which he is the sole and oft-maligned owner, will be rapidly transformed into Stanley Cup champions from a non-playoff team.

“I truly believe that we are a Stanley Cup winner within four years,” he said. “It can happen any time, but within four years.”

Melnyk speaks with certainty and obvious enthusiasm for his subject, all but guaranteeing victory and boasting of his team’s bright young stars, Thomas Chabot and Brady Tkachuk, the fistful of top prospects the Senators would snap up

Read More

NMS Consulting Selected as Strategic Advisor to Cerebain Biotech Corp. for Acquisition Project

BEVERLY HILLS, CA / ACCESSWIRE / October 6, 2020 / NMS Consulting, Inc. (“NMS”) is pleased to announce that it has been selected as strategic advisor by Cerebain Biotech Cop. (OTCPINK:CBBT) (“Cerebain”) for its planned acquisition of PKG, Inc. (“PKG”).

As part of the initial scope of services, NMS shall provide management consulting services related to the formal due diligence of the PKG operations and financials in addition to analysis related to revenue and cost synergies/savings, human capital and performance optimization, tax advisory, and mitigation strategy, risk management strategy, transaction and financing structuring to ensure optimal benefits to Cerebain and its shareholders. Additional services shall include post-merger integration, revenue growth strategies, market entry and expansion, digital transformation, cyber-security, and data privacy.

Trevor M. Saliba, Managing Partner and Global Head of Private Equity, M&A, and Strategy of NMS said, “We are very excited to continue working with Cerebain on

Read More

The advice that shaped Insitro CFO Mary Rozenman’s biotech career

Mary Rozenman initially set out to be a doctor, after watching her sister deal with uncontrolled epilepsy throughout her childhood.

But she realized in college, that blood made her cringe. Instead, Rozenman got her doctorate in organic chemistry and chemical biology from Harvard University. 

Then as a 26-year-old working under David Liu, a gene-editing pioneer, something about drug development didn’t sit right with the young chemist. Among the thousands of new discoveries each year, just a small handful of them make it through the “funnel,” she said.

“I envisioned a funnel, where you have at the top of the funnel all of these amazing discoveries and innovations that sort of move through the system,” Rozenman told Business Insider. 

“And somehow only a small handful of them get filtered into medicines that actually make it out into the real world’s drug supply,” she said.

Rozenman needed to understand how that funnel

Read More

Saskatchewan Celebrates Science During Global Biotech Week with Online Events and Activities

SASKATOON, Saskatchewan–(BUSINESS WIRE)–Sep 28, 2020–

From the Science of Beer to learning about the benefits of GMOs; Saskatchewan is celebrating science with exciting online events and activities that showcase the province’s bioscience sector. Ag-West Bio, Saskatchewan’s bioscience industry association, coordinates events with the help of a local committee.

Ag-West Bio President and CEO Karen Churchill says amid the COVID-19 pandemic, biotechnology is in the spotlight. “Saskatchewan organizations in our research cluster have joined the global effort to develop vaccines as well as preventative and treatment solutions to deal with the virus. As a community, we should take note of the achievements of our local scientists and companies. Global Biotech Week gives us an opportunity to give them a (virtual) pat on the back!”

The Government of Saskatchewan and the Cities of Regina and Saskatoon have proclaimed September 28 to October 4 as Global Biotech Week.

Saskatchewan events:

Sept. 28 —

Read More

Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities

SHANGHAI, Sept. 20, 2020 /PRNewswire/ — Viva Biotech (Shanghai) Co., Ltd. (hereinafter referred to as “Viva Biotech” or “The Company”) entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 100% of the equity interest in SYNthesis med chem (Hong Kong) Limited (hereinafter referred to as ” SYNthesis “), at the consideration of approximately US$ 80 million (equivalent to approximately HK$ 620 million). The acquisition will achieve the synergies between Viva Biotech and SYNthesis, regarding to the CRO business in the global market, which is of great strategic significance for The Company to conduct vertical integration and establish a comprehensive one-stop drug services platform.

SYNthesis is a preclinical small molecule drug discovery service contract organisation which mainly provides high-end pharmaceutical chemistry and synthetic chemistry services to its clients. SYNthesis is headquartered in Hong

Read More

Happiness Biotech Launched “Happy Buy”, Dedicated to Boost its E-Commerce Business

NANPING, China, Sept. 9, 2020 /PRNewswire/ — Happiness Biotech Group Limited (the “Company” or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the Company has set up a wholly owned subsidiary “Happy Buy (Fujian) Internet Technology Co., Ltd.”(“Happy Buy”) focusing on further developing the Company’s e-Commerce business.

Happy Buy will carry out a unique B2B e-commerce model, utilizing the Company’s advantages in supply chain and sales terminals, and leveraging various e-commerce forms to promote the sales of the Company’s products to various online distributors. Management also expects to provide e-commerce and online marketing solutions to other small and media business via Happy Buy.

“During the period our business was impacted by the COVID-19, we have carried out a variety of e-commerce attempts and achieved gratifying results, which has strengthened the Company’s determination to vigorously develop our own e-commerce business. Upon in-depth

Read More

CTT Enters into Business Development Partnership with 3 Rivers Biotech

Partnership Further Advances Aggressive Business Development Strategy

Pre-eminent Tissue Culture Company Provides Access to Substantial Network of CPG Companies

3 Rivers’ Technology Transfer Capabilities Expand CTT’s Operational Capacity

HAMILTON, ON, Sept. 8, 2020 /PRNewswire/ – CTT Pharmaceutical Holdings, Inc., (the “Company” or “CTT”) (OTC: CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, today announced that it has entered into a business development partnership with 3 Rivers Biotech, a pre-eminent tissue culture company. Under the agreement, 3 Rivers will leverage its network of suppliers to and manufacturers of Consumer Packaged Goods (CPG) to secure commercial partnerships based on CTT’s patented sublingual wafer technology.

Additionally, the agreement includes the ability for CTT to utilize 3 Rivers’ operational capabilities to execute technology transfers and project implementation for new customers, providing a cost-efficient and de-risked expansion of CTT’s operational capacity.

3 Rivers’ is one of

Read More